Literature DB >> 12664207

Pathogenesis of chronic allograft rejection.

Simone A Joosten1, Cees van Kooten, Leendert C Paul.   

Abstract

Chronic allograft nephropathy (CAN) is, besides death of the recipient with graft function, the most common cause of renal transplant loss. It is characterized by loss of function and replacement of tissue by fibrotic material. The pathogenesis is not clear, but seems to be multifactorial and involves events both early and late after transplantation. Alloantigen-dependent mechanisms seem to be crucial for the development of chronic rejection (CR). Although modern immunosuppressive drugs have reduced the number and severity of acute rejection episodes, their effects on CR are less obvious. In this review we discuss the role of direct and indirect antigen presentation in the development of CR, and we will focus on the production of antibodies directed against HLA and non-HLA antigens on the graft and their influence on CR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664207     DOI: 10.1007/s00147-003-0554-x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  12 in total

Review 1.  Gut microbiota and its implications in small bowel transplantation.

Authors:  Chenyang Wang; Qiurong Li; Jieshou Li
Journal:  Front Med       Date:  2018-03-09       Impact factor: 4.592

Review 2.  Mechanism of arterial remodeling in chronic allograft vasculopathy.

Authors:  Qichang Zheng; Shanglong Liu; Zifang Song
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

3.  Five-year follow-up after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft nephropathy.

Authors:  Sheng-Qiang Xia; Yu Fan; Ming-Yue Tan; Jun-Hua Zheng
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes.

Authors:  S Timm; C Otto; D Begrich; V Moskalenko; W Hamelmann; K Ulrichs; A Thiede; W Timmermann
Journal:  Langenbecks Arch Surg       Date:  2003-12-05       Impact factor: 3.445

5.  Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid.

Authors:  D J Jackson; C J Elson; B M Kumpel
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

6.  Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation.

Authors:  Veronika Muller; Attila J Szabo; Aaron Erdely; You-Lin Tain; Chris Baylis
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-12-07       Impact factor: 2.557

Review 7.  Immunosuppression for long-term maintenance of renal allograft function.

Authors:  Gerd Offermann
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.

Authors:  Zifang Song; Wei Li; Qichang Zheng; Dan Shang; Xiaogang Shu; Siming Guan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

9.  Immune responses to self-antigens (autoimmunity) in allograft rejection.

Authors:  Sabarinathan Ramachandran; Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Clin Transpl       Date:  2012

10.  Conversion to sirolimus of patients with chronic allograft nephropathy--a retrospective analysis of outcome and influencing factors.

Authors:  Oliver Witzke; Ondrej Viklicky; Tobias R Türk; Jens Lutz; Benjamin Wilde; Isabel Willenberg; Stefan Vitko; Uwe Heemann
Journal:  Langenbecks Arch Surg       Date:  2008-11-20       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.